Back to Search
MATTHEW ZIMNY, D.O.
D.O.
Family Medicine Physician
NPI: 1306880950IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
5101015736(MI)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
MICHIGAN STATE UNIVERSITY COLLEGE OF OSTEOPATHIC MEDICINE
Class of 2003
Research & Publications (20)
Calculation and validation of a plasma calcitonin limit for early detection of medullary thyroid carcinoma in nodular thyroid disease.
PMID 19355822·Thyroid·2009
8-other
[3D volume and SUV analysis of oncological PET studies: a voxel-based image processing tool with NSCLC as example].
PMID 17690792·Nuklearmedizin·2007
8-other
pO polarography, contrast enhanced color duplex sonography (CDS), [18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography: validated methods for the evaluation of therapy-relevant tumor oxygenation or only bricks in the puzzle of tumor hypoxia?
PMID 17598907·BMC Cancer·2007
4-observational
FDG--a marker of tumour hypoxia? A comparison with [18F]fluoromisonidazole and pO2-polarography in metastatic head and neck cancer.
PMID 16841141·Eur J Nucl Med Mol Imaging·2006
4-observational
Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
PMID 16673059·Strahlenther Onkol·2006
3-trial
[18F] fluoromisonidazole and [18F] fluorodeoxyglucose positron emission tomography in response evaluation after chemo-/radiotherapy of non-small-cell lung cancer: a feasibility study.
PMID 16515707·BMC Cancer·2006
3-trial
[Spectrometric assessment of thyroid depth within the radioiodine test].
PMID 16395494·Nuklearmedizin·2005
8-other
Increased therapeutic ratio by 18FDG-PET CT planning in patients with clinical CT stage N2-N3M0 non-small-cell lung cancer: a modeling study.
PMID 15708242·Int J Radiat Oncol Biol Phys·2005
8-other
pO(2) Polarography versus positron emission tomography ([(18)F] fluoromisonidazole, [(18)F]-2-fluoro-2'-deoxyglucose). An appraisal of radiotherapeutically relevant hypoxia.
PMID 15480509·Strahlenther Onkol·2004
3-trial
Diagnostic imaging of pancreatic cancer--the role of PET.
PMID 15458189·Front Radiat Ther Oncol·2004
6-review
FDG PET and tumour markers in the diagnosis of recurrent and metastatic breast cancer.
PMID 15146295·Eur J Nucl Med Mol Imaging·2004
6-review
[Concept and validation of a simple model of the intrathyroidal iodine kinetics].
PMID 14978537·Nuklearmedizin·2004
8-other
Radioiodine therapy in patients with hyperthyroid disorder: standard versus dosimetric activity application.
PMID 14627852·Nucl Med Commun·2003
3-trial
Mediastinal staging of lung cancer with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose positron emission tomography and a dual-head coincidence gamma camera.
PMID 12664112·Eur Radiol·2003
4-observational
Positron emission tomography scanning in gynecologic and breast cancers.
PMID 12544505·Curr Opin Obstet Gynecol·2003
4-observational
[Relevance of colour-duplex echography for detection and therapy of recurrences in the follow-up of head and neck cancer].
PMID 12486624·Laryngorhinootologie·2002
4-observational
Thyroid volume measurement in patients prior to radioiodine therapy: comparison between three-dimensional magnetic resonance imaging and ultrasonography.
PMID 12225640·Thyroid·2002
4-observational
Pre-transplant positron emission tomography (PET) using fluorine-18-fluoro-deoxyglucose (FDG) predicts outcome in patients treated with high-dose chemotherapy and autologous stem cell transplantation for non-Hodgkin's lymphoma.
PMID 12132049·Bone Marrow Transplant·2002
3-trial
Uptake of cis-4-[18 F]fluoro-L-proline in scar formation: a marker of collagen synthesis?
PMID 12089493·Nucl Med Commun·2002
4-observational
Combined image interpretation of computed tomography and hybrid PET in head and neck cancer.
PMID 11917343·Nuklearmedizin·2002
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 35429 SCHOENHERR RD
STERLING HEIGHTS, MI 48312 - Phone
- (586) 274-1145
Quick Facts
- NPI
- 1306880950
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile